SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-042155
Filing Date
2020-07-10
Accepted
2020-07-10 16:15:13
Documents
2
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2810
2 POA DOCUMENT poa.txt EX-24.3_928578 3877
  Complete submission text file 0001209191-20-042155.txt   8192
Mailing Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355
Business Address 28159 AVENUE STANFORD SUITE 220 VALENCIA CA 91355 661-367-9170
Avita Therapeutics, Inc. (Issuer) CIK: 0001762303 (see all company filings)

IRS No.: 202578762 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O AVITA MEDICAL 28159 AVENUE STANFORD, SUITE 220 VALENCIA CA 91355
Business Address
Crowe Suzanne (Reporting) CIK: 0001816242 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39059 | Film No.: 201023308